5-吗啉-4-噻吩-2-甲醛 | 24372-49-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 5-吗啉-4-噻吩-2-甲醛
• 中文别名: 5-(1-哌啶基)噻吩-2-甲醛；5-吗啡啉基-2-噻吩甲醛
• 英文名称: 5-(4-morpholinyl)thiophene-2-carboxaldehyde
• 英文别名: 5-morpholinothiophene-2-carbaldehyde；5-Formyl-2-morpholinothiophene；5-morpholin-4-yl-thiophene-2-carbaldehyde；5-(4-morpholinyl)-2-thiophenecarbaldehyde；5-Morpholino-2-thiophenecarbaldehyde；5-morpholin-4-ylthiophene-2-carbaldehyde
• CAS: 24372-49-4
• 化学式: C₉H₁₁NO₂S
• mdl: MFCD02710611
• 分子量: 197.258
• InChiKey: MWCGENRKAMIZLZ-UHFFFAOYSA-N

物化性质

• 熔点：
  126 °C
• 沸点：
  382.0±42.0 °C(Predicted)
• 密度：
  1.281±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.444
• 拓扑面积：
  57.8
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2934999090
• 储存条件：
  存储条件：2-8°C，避光，惰性气体

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Morpholinothiophene-2-carbaldehyde
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Morpholinothiophene-2-carbaldehyde
CAS number: 24372-49-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H11NO2S
Molecular weight: 197.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-吗啉-4-噻吩-2-甲醛 在 二苯基膦叠氮化物 、 silver nitrate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 24.08h， 生成 2-isocyanato-5-(4-morpholinyl)thiophene
  参考文献：
  名称：

  利奈唑胺新杂环类似物的合成

  摘要：

  我们之前已经尝试了制备5-（4-吗啉基）-2-氨基噻吩（3通过减少5-（4-吗啉基）-2-硝基噻吩（）2），以制备前体用于制备thienyloxazolidinones的作为潜在linezolid-像抗生素。该策略失败了，但使我们能够定义一个有趣的还原性芳构化反应。现在，我们已经使用另一种策略成功地生产了噻吩并恶唑烷酮，它是由5-（4-吗啉基）噻吩-2-甲醛（8）引发的。该信函描述了噻吩恶唑烷酮14的合成，噻吩恶唑烷酮14是制备具有噻吩核心的新型恶唑烷酮抗生素的关键中间体。

  DOI：

  10.1016/j.tetlet.2015.09.065
• 作为产物：
  描述：

  5-溴噻吩-2-甲醛 以 乙醚 、 水 为溶剂， 反应 0.08h， 生成 5-吗啉-4-噻吩-2-甲醛
  参考文献：
  名称：

  Convenient amination of weakly activated thiophenes, furans and selenophenes in aqueous media

  摘要：

  We describe herein a new amination procedure of weakly activated heterocyclic bromo derivatives in aqueous media. The base catalysed mechanism of this reaction is also confirmed. Moreover, the application of this strategy to the preparation of amino furans and selenophenes is outlined. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(99)00318-x

文献信息

• [EN] PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE SOUS FORME DE PYRAZOLOPYRIMIDINES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004009602A1

  公开（公告）日：2004-01-29

  The present invention relates generally to inhibitors of the kinases and more particularly to novel pyrazolopyrimidine compounds.

  本发明一般涉及激酶的抑制剂，更具体地涉及新型吡唑吡嘧啶化合物。
• Betti reaction enables efficient synthesis of 8-hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases
  作者：C. C. Thinnes、A. Tumber、C. Yapp、G. Scozzafava、T. Yeh、M. C. Chan、T. A. Tran、K. Hsu、H. Tarhonskaya、L. J. Walport、S. E. Wilkins、E. D. Martinez、S. Müller、C. W. Pugh、P. J. Ratcliffe、P. E. Brennan、A. Kawamura、C. J. Schofield

  DOI：10.1039/c5cc06095h

  日期：——

  A Betti reaction was used for efficient generation of 2OG oxygenase inhibitors, including for KDM4 demethylases.

  使用Betti反应高效生成2OG氧化酶抑制剂，包括KDM4去甲基酶。
• A facile preparation of trisubstituted amino-furan and -thiophene derivatives
  作者：Raouf Medimagh、Sylvain Marque、Damien Prim、Saber Chatti

  DOI：10.1039/c1ob05216k

  日期：——

  β-Alkylation of amino-furan and -thiophene heterocycles is described through metal-, acid- and base-free carbon–carbon bond formation. The ability of both heterocycles to undergo selective β-alkylation is compared by mean of experimental and theoretical data. The presence of chiral amine substituents induced the diastereoselective generation of the newly formed additional stereocenter.

  β-烷基化 氨基呋喃-噻吩杂环通过无金属，无酸和无碱的碳-碳键形成来描述。通过实验和理论数据比较了两个杂环进行选择性β-烷基化的能力。手性胺取代基的存在诱导了新形成的另外的立体中心的非对映选择性的产生。
• [EN] BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR<br/>[FR] DÉRIVÉ DE BENZÈNE OU DE THIOPHÈNE ET SON UTILISATION EN TANT QU'INHIBITEUR DE LA VAP-1
  申请人：R TECH UENO LTD

  公开号：WO2009145360A1

  公开（公告）日：2009-12-03

  The present invention provides a novel benzene derivative or thiophene derivative useful as a VAP-1 inhibitor, or a medicament for the prophylaxis or treatment of a VAP-1 associated disease and the like, namely, a compound represented by the formula (I): wherein each symbol is as defined in the present specification, or a pharmaceutically acceptable salt thereof.

  本发明提供了一种新颖的苯衍生物或噻吩衍生物，可用作VAP-1抑制剂，或用作预防或治疗与VAP-1相关的疾病等的药物，即由以下式（I）表示的化合物：其中每个符号如本说明书中所定义，或其药学上可接受的盐。
• [EN] HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES<br/>[FR] COMPOSÉS À PETITES MOLÉCULES MIMÉTIQUES DES FACTEURS DE CROISSANCE HÉMATOPOÏÉTIQUE ET LEURS UTILISATIONS
  申请人：LIGAND PHARM INC

  公开号：WO2011046954A1

  公开（公告）日：2011-04-21

  The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.

  目前的实施例涉及具有生理效应的化合物，例如激活造血生长因子受体。目前的实施例还涉及利用这些化合物来治疗各种疾病、疾病和疾患，如造血状况和疾病。